Valuation: Harbin Pharmaceutical Group Co., Ltd.

Market Cap 14.31B 2.14B 1.94B 1.79B 1.62B 3.06B 201B 3.15B 21.47B 8.53B 108B 8.04B 7.87B 343B P/E 2026 *
23.7x
P/E 2027 * 20.3x
Enterprise Value 14.31B 2.14B 1.94B 1.79B 1.62B 3.06B 201B 3.15B 21.47B 8.53B 108B 8.04B 7.87B 343B EV / Sales 2026 *
0.87x
EV / Sales 2027 * 0.84x
Free-Float
48.71%
Yield 2026 *
-
Yield 2027 * -
1 day-1.05%
1 week-2.07%
Current month+2.34%
1 month-14.59%
3 months-35.53%
6 months+46.02%
Current year+64.64%
1 week 5.55
Extreme 5.55
5.92
1 month 5.04
Extreme 5.04
6.77
Current year 2.84
Extreme 2.84
9.86
1 year 2.84
Extreme 2.84
9.86
3 years 2.41
Extreme 2.41
9.86
5 years 2.41
Extreme 2.41
9.86
10 years 2.38
Extreme 2.38
9.86
Manager TitleAgeSince
Chief Executive Officer 64 27/12/2023
Director of Finance/CFO 54 24/12/2004
Investor Relations Contact 45 27/04/2022
Director TitleAgeSince
Director/Board Member 60 08/01/2021
Chairman 56 27/12/2023
Director/Board Member 46 27/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
1/7/24 Sell 36,000 0.0014%
1/7/24 Sell 27,000 0.0011%
1/7/24 Sell

Chief Financial Officer

90,000 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-2.07%+51.06%+56.47% 2.14B
-0.70%+4.58%+40.23%+138.79% 1,271B
+1.11%+4.11%+45.85%+92.54% 683B
-0.18%+2.15%+26.25%+112.46% 520B
-0.68%+3.54%+39.39%+69.26% 389B
-0.16%+0.01%+60.69%+44.94% 362B
-0.02%+0.90%+26.99%+58.69% 304B
+0.28%+0.23%+3.47%+36.24% 286B
-0.22%+1.47%+38.89%+74.73% 253B
-1.05%+0.23%+36.10%+121.22% 208B
Average -0.07%+1.79%+36.89%+80.53% 428B
Weighted average by Cap. +0.24%+2.67%+37.41%+96.72%

Financials

2026 *2027 *
Net sales 16.4B 2.46B 2.22B 2.05B 1.86B 3.5B 231B 3.61B 24.62B 9.78B 123B 9.22B 9.03B 393B 16.94B 2.54B 2.29B 2.12B 1.92B 3.62B 239B 3.73B 25.42B 10.1B 128B 9.52B 9.32B 406B
Net income 607M 90.88M 82.19M 75.86M 68.67M 130M 8.54B 133M 911M 362M 4.57B 341M 334M 14.54B 699M 105M 94.68M 87.39M 79.1M 149M 9.84B 154M 1.05B 417M 5.26B 393M 385M 16.75B
Net Debt - -
Projected Income Statement - Annual - Harbin Pharmaceutical Group Co., Ltd.
Logo Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, wholesale and retail of pharmaceutical. The Company is mainly engaged in two businesses. The pharmaceutical industry business is mainly engaged in the research, development and manufacturing of chemical raw materials, chemical preparations, biological preparations, traditional Chinese medicine and health care products. The pharmaceutical commercial business is mainly engaged in pharmaceutical commercial wholesale business and pharmaceutical commercial retail business. The Company's products mainly include zinc gluconate oral solution, calcium iron zinc oral solution, compound calcium gluconate oral solution, amoxicillin capsules and Shuanghuanglian oral solution. The Company's products are mainly used in digestive, respiratory, anti-infectious, cardiovascular and cerebrovascular and anti-tumor treatment fields.
Employees
10,039
Date Price Change Volume
12/11/26 CNY 5.680 -1.05% 272,031,110
11/11/26 CNY 5.740 -0.52% 204,183,991
10/11/26 CNY 5.770 +1.41% 213,429,063
09/11/26 CNY 5.690 +2.52% 226,881,246
06/11/26 CNY 5.550 -4.31% 203,274,153
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.680CNY
Average target price
9.160CNY
Spread / Average Target
+61.27%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Harbin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 600664 Stock